Teva Pharmaceutical Industries Ltd., of Jerusalem, published a letter that Erez Vigodman, its president and CEO, sent to Robert J. Coury, executive chairman of the board of Mylan NV, of Potters Bar, UK, reiterating Teva's interest in acquiring Mylan.